RVPH
RVPH
NASDAQ · Pharmaceuticals

Reviva Pharmaceuticals Holdi

$0.48
-0.02 (-4.40%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 2 18%
Sell 0 0%
Price Target
Analyst Price Target +2,477.1% upside
Low Target $10.29
Average Target $12.37
High Target $18.62
Current Price $0.48
Current
$0.48
Target
$12.37
$10.29 $12.37 avg $18.62
Scenario Analysis
Bear Case
$10.29
2,043.8%
Low target
Base Case
$12.37
+2,477.1%
Avg target
Bull Case
$18.62
+3,779.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$17.20
-97.2% from high
52-Week Low
$0.26
+83.2% from low
Target vs 52W High
$12.37
-28.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +194.2%